The HIV-1 reverse transcriptase connection domain from treatment-experienced patients contributes to AZT resistance

被引：0
|
作者：
Nikolenko, G. N.
Frankenberry, K. A.
Palmer, S.
Maldarelli, F.
Mellors, J. W.
Coffin, J. M.
Pathak, V. K.
机构：
[1] NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [41] Effectiveness of tipranavir versus darunavir as a salvage therapy in HIV-1 treatment-experienced patients
    Carlos Dominguez-Hermosillo, Juan
    Antonio Mata-Marin, Jose
    Estela Herrera-Gonzalez, Norma
    Chavez-Garcia, Marcelino
    Huerta-Garcia, Gloria
    Nunez-Rodriguez, Nohemi
    Gerardo Garcia-Gamez, Jose
    Jimenez-Romero, Anai
    Enrique Gaytan-Martinez, Jesus
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (09): : 982 - 987
  • [42] Enhanced NRTI and NNRTI resistance is associated with mutations in the HIV-1 reverse transcriptase connection subdomain of subtype C patients
    Delviks-Frankenberry, K. A.
    Lengruber, R. B.
    Santos, A. F.
    Soares, M. A.
    Kearney, M.
    Maldarelli, F.
    Coffin, J. M.
    Pathak, V. K.
    ANTIVIRAL THERAPY, 2010, 15 : A78 - A78
  • [43] The reverse transcriptase of HIV-1: role of the domain connection and RNase H in anti-retroviral resistors
    Roquebert, Benedicte
    Leleu, Juliette
    VIROLOGIE, 2010, 14 (02) : 129 - 139
  • [44] Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection
    Kuemmerle, Tim
    Lehmann, Clara
    Hartmann, Pia
    Wyen, Christoph
    Faetkenheuer, Gerd
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (11) : 1773 - 1785
  • [45] Etravirine A Review of its Use in the Management of Treatment-Experienced Patients with HIV-1 Infection
    Croxtall, Jamie D.
    DRUGS, 2012, 72 (06) : 847 - 869
  • [46] NEVIRAPINE BINDING DOMAIN FROM HIV-1 REVERSE-TRANSCRIPTASE CONFERS SENSITIVITY TO HIV-2 REVERSE-TRANSCRIPTASE
    BACOLLA, A
    HANSEN, GL
    ROSE, JM
    SHIH, CK
    GRIFFIN, JA
    FASEB JOURNAL, 1992, 6 (01): : A60 - A60
  • [47] Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis
    Ray, AS
    Murakami, E
    Basavapathruni, A
    Vaccaro, JA
    Ulrich, D
    Chu, CK
    Schinazi, RF
    Anderson, KS
    BIOCHEMISTRY, 2003, 42 (29) : 8831 - 8841
  • [48] Molecular Origins of HIV-1 reverse Transcriptase Resistance to Efavirenz
    Deredge, Daniel J.
    Howard, Kathryn J.
    Seckler, James M.
    Barkley, Mary D.
    Wintrode, Patrick L.
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 227 - 227
  • [49] Determination of capravirine inhibitory quotient in HIV-infected, non-nucleoside reverse transcriptase inhibitor treatment-experienced patients
    Hammond, J
    Raber, S
    Amantea, M
    Grettenberger, H
    Shetty, B
    Hawley, P
    Patick, AK
    ANTIVIRAL THERAPY, 2003, 8 (03) : U135 - U136
  • [50] Reverse Transcriptase Substitution at Codons 208 and 228 Among Treatment-Experienced HIV-1 Subtype-C-Infected Indian Patients Is Strongly Associated With Thymidine Analogue Mutations
    Saravanan, Shanmugam
    Madhavan, Vidya
    Solomon, Sunil S.
    Kantor, Rami
    Katzenstein, David
    Sivamalar, Sathasivam
    Kumarasamy, Nagalingeswaran
    Smith, Davey M.
    Mayer, Kenneth H.
    Solomon, Suniti
    Balakrishnan, Pachamuthu
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (02) : E26 - E27
12345